The main purposes of the AIDA protocol are to test the role of intermittent maintenance therapy with ATRA, standard maintenance chemotherapy with methotrexate and 6-mercaptopurine of both in PCR negative patients at the end of the consolidation phase and to evaluate the role of allogeneic or autologous bone marrow transplantation in PCR positive patients at the end of the consolidation phase.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
1,068
To assess the role of maintenance therapy with ATRA, chemotherapy or both in PCR negative patients at the end of the consolidation phase.
To assess the role of allogeneic or autologous bone marrow transplantation in PCR positive patients at the end of the consolidation phase
To evaluate the role of maintenance therapy with ATRA and chemotherapy in PCR positive patients at the end of the consolidation phase not eligible for a BMT procedure
To assess the efficacy, in terms of CR rate, and toxicity of an induction treatment combining ATRA with Idarubicin
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Department of Hematology - Middelheim Ziekenhuis
Antwerp, Belgium
RECRUITINGDepartment of Hematology - Klinikum Grosshadem - Ludwig Maxmilians
München, Germany
RECRUITINGS.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo
Alessandria, Italy
RECRUITINGAzienda Ospedaliera - Nuovo Ospedale "Torrette"
Ancona, Italy
RECRUITINGU.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno
Ascoli Piceno, Italy
RECRUITINGAz.Ospedaliera S.G.Moscati
Avellino, Italy
RECRUITINGCentro di Riferimento Oncologico
Aviano, Italy
RECRUITINGUnità Operativa Ematologia 1 - Università degli Studi di Bari
Bari, Italy
RECRUITINGEmatologia con trapianto-Università degli Studi di Bari Aldo Moro
Bari, Italy
RECRUITINGAzienda Ospedaliera - Papa Giovanni XXIII
Bergamo, Italy
RECRUITING...and 70 more locations